The Priority Review

Regulation Brief

FDA proposes rule that N-acetyl-L-cysteine is not excluded from the dietary supplement definition

The FDA is proposing a regulation that finds N-acetyl-L-cysteine (NAC) is not excluded from the dietary supplement definition in the FD&C Act, which would allow products containing NAC to be lawfully marketed as dietary supplements if they otherwise meet the definition. Comments on the proposed rule are due by January 19, 2027.

Primary source

Federal Register proposed rule, November 17, 2026

Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition

Read the source: Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition federalregister.gov

Machine-summarized from the source above; not independently reported. How we use automation